790 related articles for article (PubMed ID: 15362175)
1. Rett syndrome: of girls and mice--lessons for regression in autism.
Glaze DG
Ment Retard Dev Disabil Res Rev; 2004; 10(2):154-8. PubMed ID: 15362175
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome.
Moretti P; Bouwknecht JA; Teague R; Paylor R; Zoghbi HY
Hum Mol Genet; 2005 Jan; 14(2):205-20. PubMed ID: 15548546
[TBL] [Abstract][Full Text] [Related]
3. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.
Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP
Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735
[TBL] [Abstract][Full Text] [Related]
4. MeCP2 in neurons: closing in on the causes of Rett syndrome.
Caballero IM; Hendrich B
Hum Mol Genet; 2005 Apr; 14 Spec No 1():R19-26. PubMed ID: 15809268
[TBL] [Abstract][Full Text] [Related]
5. The story of Rett syndrome: from clinic to neurobiology.
Chahrour M; Zoghbi HY
Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
[TBL] [Abstract][Full Text] [Related]
6. Histone modifications in Rett syndrome lymphocytes: a preliminary evaluation.
Kaufmann WE; Jarrar MH; Wang JS; Lee YJ; Reddy S; Bibat G; Naidu S
Brain Dev; 2005 Aug; 27(5):331-9. PubMed ID: 16023547
[TBL] [Abstract][Full Text] [Related]
7. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
8. Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms.
Fukuda T; Yamashita Y; Nagamitsu S; Miyamoto K; Jin JJ; Ohmori I; Ohtsuka Y; Kuwajima K; Endo S; Iwai T; Yamagata H; Tabara Y; Miki T; Matsuishi T; Kondo I
Brain Dev; 2005 Apr; 27(3):211-7. PubMed ID: 15737703
[TBL] [Abstract][Full Text] [Related]
9. Social impairments in Rett syndrome: characteristics and relationship with clinical severity.
Kaufmann WE; Tierney E; Rohde CA; Suarez-Pedraza MC; Clarke MA; Salorio CF; Bibat G; Bukelis I; Naram D; Lanham DC; Naidu S
J Intellect Disabil Res; 2012 Mar; 56(3):233-47. PubMed ID: 21385260
[TBL] [Abstract][Full Text] [Related]
10. Another patient with MECP2 mutation without classic Rett syndrome phenotype.
Milani D; Pantaleoni C; D'Arrigo S; Selicorni A; Riva D
Pediatr Neurol; 2005 May; 32(5):355-7. PubMed ID: 15866439
[TBL] [Abstract][Full Text] [Related]
11. MECP2 mutations in Danish patients with Rett syndrome: high frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern.
Nielsen JB; Henriksen KF; Hansen C; Silahtaroglu A; Schwartz M; Tommerup N
Eur J Hum Genet; 2001 Mar; 9(3):178-84. PubMed ID: 11313756
[TBL] [Abstract][Full Text] [Related]
12. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
Braunschweig D; Simcox T; Samaco RC; LaSalle JM
Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of Japanese patients with Rett syndrome: Identification of five novel mutations and genotype-phenotype correlation.
Yamada Y; Miura K; Kumagai T; Hayakawa C; Miyazaki S; Matsumoto A; Kurosawa K; Nomura N; Taniguchi H; Sonta SI; Yamanaka T; Wakamatsu N
Hum Mutat; 2001 Sep; 18(3):253. PubMed ID: 11524741
[TBL] [Abstract][Full Text] [Related]
14. Cognitive and social functions and growth factors in a mouse model of Rett syndrome.
Schaevitz LR; Moriuchi JM; Nag N; Mellot TJ; Berger-Sweeney J
Physiol Behav; 2010 Jun; 100(3):255-63. PubMed ID: 20045424
[TBL] [Abstract][Full Text] [Related]
15. Classic Rett syndrome in a boy with R133C mutation of MECP2.
Masuyama T; Matsuo M; Jing JJ; Tabara Y; Kitsuki K; Yamagata H; Kan Y; Miki T; Ishii K; Kondo I
Brain Dev; 2005 Sep; 27(6):439-42. PubMed ID: 16122633
[TBL] [Abstract][Full Text] [Related]
16. Rett syndrome: a prototypical neurodevelopmental disorder.
Neul JL; Zoghbi HY
Neuroscientist; 2004 Apr; 10(2):118-28. PubMed ID: 15070486
[TBL] [Abstract][Full Text] [Related]
17. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.
Gemelli T; Berton O; Nelson ED; Perrotti LI; Jaenisch R; Monteggia LM
Biol Psychiatry; 2006 Mar; 59(5):468-76. PubMed ID: 16199017
[TBL] [Abstract][Full Text] [Related]
18. Altered methylation pattern of the G6 PD promoter in Rett syndrome.
Huppke P; Bohlander S; Krämer N; Laccone F; Hanefeld F
Neuropediatrics; 2002 Apr; 33(2):105-8. PubMed ID: 12075494
[TBL] [Abstract][Full Text] [Related]
19. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional repressor Mecp2 regulates terminal neuronal differentiation.
Matarazzo V; Cohen D; Palmer AM; Simpson PJ; Khokhar B; Pan SJ; Ronnett GV
Mol Cell Neurosci; 2004 Sep; 27(1):44-58. PubMed ID: 15345242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
